Home > Healthcare > Pharmaceuticals > Active Pharmaceutical Ingredients > Capecitabine Market
Capecitabine Market Share
- Report ID: GMI6855
- Published Date: Oct 2023
- Report Format: PDF
Capecitabine Market Share
Major players operating in the capecitabine is as mentioned below:
- Sun Pharmaceutical Industries Ltd
- Shilpa Medicare limited
- Atom Pharma
- Global Calcium
- LGM Pharma
- Dr. Reddy’s Laboratories Ltd
- Cipla Ltd
- Zeon Pharma
- Avanscure Lifesciences Pvt Ltd
- Hepartex
Frequently Asked Questions (FAQ) :
Capecitabine industry size was USD 408.2 million in 2022 and may reach USD 652.9 million by 2032 driven by rising importance in offering significant clinical effectiveness in treating different cancer
The breast cancer indication segment may record USD 265.8 million by end of 2032 driven by the growing prescription for the treatment of metastatic breast cancer due to its proven efficacy.
North America market size may reach USD 252.5 million by end of 2032 due to the presence of well-established network of domestic and international pharmaceutical manufacturers
Some of the major capecitabine providers are Global Calcium, Sun Pharmaceutical Industries Ltd, Shilpa Medicare limited, Atom Pharma, Avanscure Lifesciences Pvt Ltd, Cipla Ltd, LGM Pharma, Dr. Reddy’s Laboratories Ltd, and Zeon Pharma
Capecitabine Market Scope
×
Get a free sample of
Capecitabine Market
Inquiry Before Buying
Get special pricing options on this report
Request Sectional Data
Over 70% of our clients customize reports to fit their needs. Please tell us how you would like to customize yours
below